Showing results (841-850 of 1,089) with videos related to

Sort By:
Pageof 109
Nature Communications|January 10, 2015
The evolution of cyclopropenium ions into functional polyelectrolytesYivan Jiang, Jessica L Freyer, Pepa Cotanda, et al.
Molecular Genetics and Metabolism|May 30, 2017
Detection of 6-demethoxyubiquinone in CoQ10 deficiency disorders: Insights into enzyme interactions and identification of potential therapeuticsDiran Herebian, Annette Seibt, Sander H J Smits, et al.
European Urology Oncology|November 3, 2019
Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer PatientsDenis Maillet, Nathalie Allioli, Julien Peron, et al.
Leukemia & Lymphoma|May 11, 2024
A de novo germline RUNX1 variant preceding development of concurrent T-lymphoblastic leukemia and myelodysplastic syndromeCassandra P Wang, Juanita E Ferreira, Alexander Placek, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 11, 2017
Prevalence and correlates of health information-seeking among Hispanic and non-Hispanic childhood cancer survivorsKimberly A Miller, Cynthia N Ramirez, Katherine Y Wojcik, et al.
International Journal of Molecular Sciences|April 20, 2016
In Vitro Model for Hepatotoxicity Studies Based on Primary Human Hepatocyte Cultivation in a Perfused 3D Bioreactor SystemFanny Knöspel, Frank Jacobs, Nora Freyer, et al.
The American Journal of Pediatric Hematology/Oncology|November 1, 1993
Brief unconscious sedation for painful pediatric oncology procedures. Intravenous methohexital with appropriate monitoring is safe and effectiveA E Schwanda, D R Freyer, D J Sanfilippo, et al.
The American Journal of Pathology|June 19, 2016
Proatherosclerotic Effect of the α1-Subunit of Soluble Guanylyl Cyclase by Promoting Smooth Muscle Phenotypic SwitchingMaria Segura-Puimedon, Evanthia Mergia, Jaafar Al-Hasani, et al.
Infection Control and Hospital Epidemiology|August 31, 2019
Guideline implementation is effective at reducing proton pump inhibitor use in hematology-oncology units: A multidisciplinary intervention for reducing Clostridioides difficile riskMatthew J Ziegler, Craig Freyer, Daniel Landsburg, et al.
Nature Communications|March 5, 2024
Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO groupGilles Freyer, Anne Floquet, Olivier Tredan, et al.
Pageof 109